For help on how to get the results you want, see our search tips.
9769 results
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam Hospira (updated)
levetiracetam, Epilepsy
Date of authorisation: 07/01/2014,
, Revision: 15, Authorised, Last updated: 03/12/2020
-
List item
Human medicine European public assessment report (EPAR): Abilify Maintena (updated)
aripiprazole, Schizophrenia
Date of authorisation: 14/11/2013, Revision: 18, Authorised, Last updated: 02/12/2020 -
List item
Human medicine European public assessment report (EPAR): Renvela (updated)
sevelamer carbonate, Hyperphosphatemia, Renal Dialysis
Date of authorisation: 09/06/2009, Revision: 22, Authorised, Last updated: 02/12/2020 -
List item
Human medicine European public assessment report (EPAR): Hycamtin (updated)
topotecan, Ovarian Neoplasms, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 12/11/1996, Revision: 31, Authorised, Last updated: 02/12/2020 -
List item
Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated)
bortezomib, Multiple Myeloma
Date of authorisation: 14/11/2019,, Revision: 3, Authorised, Last updated: 02/12/2020
-
List item
Veterinary medicine European public assessment report (EPAR): Purevax RCP FeLV (updated)
Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline Calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97), Cats
Date of authorisation: 23/02/2005, Revision: 13, Authorised, Last updated: 01/12/2020 -
List item
Veterinary medicine European public assessment report (EPAR): Purevax RCPCh FeLV (updated)
Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline Calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97), Cats
Date of authorisation: 23/02/2005, Revision: 13, Authorised, Last updated: 01/12/2020 -
List item
Human medicine European public assessment report (EPAR): Remsima (updated)
infliximab, Arthritis, Psoriatic, Spondylitis, Ankylosing, Colitis, Ulcerative, Psoriasis, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 10/09/2013,
, Revision: 21, Authorised, Last updated: 01/12/2020
-
List item
Human medicine European public assessment report (EPAR): Talmanco (previously Tadalafil Generics) (updated)
tadalafil, Hypertension, Pulmonary
Date of authorisation: 09/01/2017,, Revision: 5, Authorised, Last updated: 01/12/2020
-
List item
Human medicine European public assessment report (EPAR): Enyglid (updated)
repaglinide, Diabetes Mellitus, Type 2
Date of authorisation: 13/10/2009,, Revision: 7, Authorised, Last updated: 01/12/2020
-
List item
Human medicine European public assessment report (EPAR): Firazyr (updated)
icatibant, Angioedemas, Hereditary
Date of authorisation: 11/07/2008, Revision: 18, Authorised, Last updated: 01/12/2020 -
List item
Human medicine European public assessment report (EPAR): Amsparity (updated)
adalimumab, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Psoriasis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Uveitis, Colitis, Ulcerative, Crohn Disease, Hidradenitis Suppurativa
Date of authorisation: 13/02/2020,
, , Revision: 1, Authorised, Last updated: 01/12/2020
-
List item
Human medicine European public assessment report (EPAR): Kanuma (updated)
sebelipase alfa, Lipid Metabolism, Inborn Errors
Date of authorisation: 28/08/2015,, 
, 
, Revision: 5, Authorised, Last updated: 01/12/2020
-
List item
Human medicine European public assessment report (EPAR): Aptivus (updated)
tipranavir, HIV Infections
Date of authorisation: 25/10/2005, Revision: 39, Authorised, Last updated: 01/12/2020 -
List item
Human medicine European public assessment report (EPAR): Eklira Genuair (updated)
aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/07/2012,, Revision: 17, Authorised, Last updated: 01/12/2020
-
List item
Human medicine European public assessment report (EPAR): Entyvio (updated)
vedolizumab, Colitis, Ulcerative, Crohn Disease
Date of authorisation: 22/05/2014, Revision: 17, Authorised, Last updated: 30/11/2020 -
List item
Human medicine European public assessment report (EPAR): Lenvima (updated)
lenvatinib mesilate, Thyroid Neoplasms
Date of authorisation: 28/05/2015,, , Revision: 13, Authorised, Last updated: 30/11/2020
-
List item
Human medicine European public assessment report (EPAR): Dovato (updated)
dolutegravir sodium, lamivudine, HIV Infections
Date of authorisation: 01/07/2019, Revision: 5, Authorised, Last updated: 30/11/2020 -
List item
Veterinary medicine European public assessment report (EPAR): Kexxtone (updated)
monensin (as monensin sodium), Cattle (cows and heifers)
Date of authorisation: 28/01/2013, Revision: 7, Authorised, Last updated: 30/11/2020 -
List item
Human medicine European public assessment report (EPAR): Kisplyx (updated)
lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016,, , Revision: 11, Authorised, Last updated: 30/11/2020
-
List item
Human medicine European public assessment report (EPAR): Mylotarg (updated)
gemtuzumab ozogamicin, Leukemia, Myeloid, Acute
Date of authorisation: 19/04/2018,, , Revision: 6, Authorised, Last updated: 30/11/2020
-
List item
Human medicine European public assessment report (EPAR): Evoltra (updated)
clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 29/05/2006,, 
, Revision: 29, Authorised, Last updated: 30/11/2020
-
List item
Human medicine European public assessment report (EPAR): Benepali (updated)
etanercept, Arthritis, Psoriatic, Arthritis, Rheumatoid, Psoriasis
Date of authorisation: 13/01/2016,, , Revision: 12, Authorised, Last updated: 30/11/2020
-
List item
Human medicine European public assessment report (EPAR): Kevzara (updated)
sarilumab, Arthritis, Rheumatoid
Date of authorisation: 23/06/2017,, Revision: 4, Authorised, Last updated: 30/11/2020
-
List item
Human medicine European public assessment report (EPAR): Cholestagel (updated)
colesevelam (as hydrochloride), Hypercholesterolemia
Date of authorisation: 09/03/2004, Revision: 22, Authorised, Last updated: 30/11/2020